Inflammation clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
This study is a double blinded, placebo-controlled, randomized, parallel group study, designed to compare the efficacy and safety of VB-201 80mg taken orally once daily to placebo for anti-inflammation in HIV-infected subjects.
San Francisco, California